Project Number 261108.01-WATTERSON-2011 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2011 View Full Project Details for De-risking a novel kinase-targeted lead compound for future AD drug development Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator WATTERSON, DANIEL MARTIN Principal Investigator First Name DANIEL MARTIN Principal Investigator Last Name WATTERSON Awardee Organization NORTHWESTERN UNIVERSITY AT CHICAGO Awardee State Illinios Contact PI Country United States Project Detail Funding Opportunity Announcement General RFP FY Overall Cost $135,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
